Oragenics Inc

ASE:OGEN   3:38:34 PM EDT
0.46
-0.01 (-2.04%)
Products

Oragenics Extends Collaboration With National Research Council Of Canada To Develop Vaccine Against Omicron Variant

Published: 12/20/2021 13:38 GMT
Oragenics Inc (OGEN) - Oragenics Extends Collaboration With National Research Council of Canada to Develop Vaccine Against Omicron Variant.
Oragenics - Agreement Extends Current Licensing & Collaboration Agreement to Include Rapid Production of Omicron-specific Intranasal Vaccine Candidates.
Oragenics Inc - Agreement Will Enable Co to Pursue an Intranasal Vaccine Designed to Protect Against Sars-cov-2 Omicron Variant.